FR2446111A1 - Procede de preparation d'antigenes et vaccins obtenus selon ce procede - Google Patents
Procede de preparation d'antigenes et vaccins obtenus selon ce procedeInfo
- Publication number
- FR2446111A1 FR2446111A1 FR7901301A FR7901301A FR2446111A1 FR 2446111 A1 FR2446111 A1 FR 2446111A1 FR 7901301 A FR7901301 A FR 7901301A FR 7901301 A FR7901301 A FR 7901301A FR 2446111 A1 FR2446111 A1 FR 2446111A1
- Authority
- FR
- France
- Prior art keywords
- sodium
- vaccines
- complexes
- prod
- solubilisation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000427 antigen Substances 0.000 title abstract 4
- 102000036639 antigens Human genes 0.000 title abstract 4
- 108091007433 antigens Proteins 0.000 title abstract 4
- 230000002209 hydrophobic effect Effects 0.000 title abstract 4
- 229910052708 sodium Inorganic materials 0.000 title abstract 3
- 239000011734 sodium Substances 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 102000016943 Muramidase Human genes 0.000 title abstract 2
- 108010014251 Muramidase Proteins 0.000 title abstract 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 title abstract 2
- 239000004325 lysozyme Substances 0.000 title abstract 2
- 229960000274 lysozyme Drugs 0.000 title abstract 2
- 235000010335 lysozyme Nutrition 0.000 title abstract 2
- 244000005700 microbiome Species 0.000 title abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 title 1
- 229940099352 cholate Drugs 0.000 title 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 title 1
- 230000000890 antigenic effect Effects 0.000 abstract 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 abstract 2
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000356 contaminant Substances 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 239000012134 supernatant fraction Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7901301A FR2446111A1 (fr) | 1979-01-12 | 1979-01-12 | Procede de preparation d'antigenes et vaccins obtenus selon ce procede |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7901301A FR2446111A1 (fr) | 1979-01-12 | 1979-01-12 | Procede de preparation d'antigenes et vaccins obtenus selon ce procede |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2446111A1 true FR2446111A1 (fr) | 1980-08-08 |
| FR2446111B1 FR2446111B1 (enrdf_load_stackoverflow) | 1982-07-02 |
Family
ID=9220943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7901301A Granted FR2446111A1 (fr) | 1979-01-12 | 1979-01-12 | Procede de preparation d'antigenes et vaccins obtenus selon ce procede |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2446111A1 (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0182401A1 (en) * | 1984-10-19 | 1986-05-28 | De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur | Vaccines comprising immunogenic protein or peptide complexes |
| WO1995015768A1 (de) * | 1993-12-09 | 1995-06-15 | Heinrich Exner | Adjuvans für antigene, verfahren zur herstellung und verwendung |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE633375A (enrdf_load_stackoverflow) * |
-
1979
- 1979-01-12 FR FR7901301A patent/FR2446111A1/fr active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE633375A (enrdf_load_stackoverflow) * |
Non-Patent Citations (1)
| Title |
|---|
| CA1972 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0182401A1 (en) * | 1984-10-19 | 1986-05-28 | De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur | Vaccines comprising immunogenic protein or peptide complexes |
| WO1995015768A1 (de) * | 1993-12-09 | 1995-06-15 | Heinrich Exner | Adjuvans für antigene, verfahren zur herstellung und verwendung |
| DE4499552C1 (de) * | 1993-12-09 | 1997-07-17 | Heinrich Dr Exner | Adjuvans für Antigene, Verfahren zur Herstellung und Verwendung |
| US5904925A (en) * | 1993-12-09 | 1999-05-18 | Exner; Heinrich | Adjuvant for antigens, and process for making |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2446111B1 (enrdf_load_stackoverflow) | 1982-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Monneron et al. | Isolation of plasma and nuclear membranes of thymocytes. I. Enzymatic composition and ultrastructure | |
| JP2001526902A5 (enrdf_load_stackoverflow) | ||
| GB1439847A (en) | Bacterial extracts | |
| Kahan | Isolation of a soluble transplantation antigen | |
| CA1149376A (en) | Process for preparing water-soluble compounds derived from extracts of streptomyces stimulosus, and water-soluble compounds so obtained | |
| DE1939341A1 (de) | Cephalosporinderivate und Verfahren zu ihrer Herstellung | |
| EP0731165A3 (en) | Human T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160 | |
| FR2446111A1 (fr) | Procede de preparation d'antigenes et vaccins obtenus selon ce procede | |
| Dodgson et al. | Studies on sulphatases. 8. The arylsulphatase of a strain of Alcaligenes metalcaligenes isolated from inter-tidal mud | |
| Barry et al. | L-Fucosamine and 4-oxo-norleucine as constituents in mucopolysaccharides of certain enteric bacteria | |
| EP0004137B1 (en) | Immunogenic cell envelope preparations | |
| Knowles et al. | Isolation and characterization of plasma membranes from transplantable human astrocytoma, oat cell carcinoma, and melanomas | |
| FUJII et al. | UCE1022, a new antitumor antibiotic with topoisomerase I mediated DNA cleavage activity, from Paecilomyces | |
| GB1567106A (en) | Microbial fractions | |
| Wolff et al. | Recovery of soluble feline oncornavirus-associated cell membrane antigen from large volumes of tissue culture fluids | |
| JPS568687A (en) | Preparation of creatinase | |
| US4729955A (en) | Method of producing reverse transcriptase | |
| CA2114629C (en) | Receptor conjugates for targeting antibiotics to bacteria | |
| Singh et al. | Effect of xenogeneic immune RNA on normal human lymphocytes against human osteosarcoma cells in vitro | |
| Lee et al. | Role of epoxide in neocarzinostatin chromophore stability and action. | |
| IT9021332A1 (it) | Exopolimero ottenuto a partire da ceppi selezionati del genere bifidobaceterium, suo procedimento di preparazione e composizioni farmaceutiche che lo contengono | |
| Olarte | Demonstration of the “M” Protein in Culture Filtrates of Hemolytic Streptococci of Group A | |
| Homma et al. | The surface structure of Pseudomonas aeruginosa | |
| Kupchan et al. | Zygadenus alkaloids. II. The occurrence of hypotensive germine esters in Zygadenus venenosus | |
| Kjellen | On the capacity of pepsin-digested antibody to neutralize adenovirus infectivity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |